Insider Transactions in Q3 2022 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2022
|
Aquilo Capital Management, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,901,796
-19.65%
|
$3,803,592
$2.25 P/Share
|
|
Sep 15
2022
|
Frank E Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 15
2022
|
Kathleen Tregoning |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 15
2022
|
Patrick V.J.J. Vink |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 15
2022
|
Cynthia Smith |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 15
2022
|
John C Pottage Jr |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 15
2022
|
Scott Thomas Jackson |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 15
2022
|
Milind Deshpande |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+32.29%
|
-
|
|
Sep 12
2022
|
Kamal Hamed Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
210,000
+50.0%
|
-
|
|
Aug 29
2022
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
6,017
-9.69%
|
$0
$0.89 P/Share
|